NasdaqCM - Delayed Quote USD

Celldex Therapeutics, Inc. (CLDX)

38.53 -1.10 (-2.78%)
At close: April 18 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,883.00
6,883.00
2,357.00
4,651.00
7,418.00
Operating Expense
148,925.00
148,925.00
109,453.00
73,799.00
56,990.00
Operating Income
-142,042.00
-142,042.00
-107,096.00
-69,148.00
-49,572.00
Other Income Expense
613.00
613.00
-5,229.00
-1,590.00
-11,375.00
Pretax Income
-141,429.00
-141,429.00
-112,325.00
-70,738.00
-60,947.00
Tax Provision
--
--
--
-227.00
-1,167.00
Net Income Common Stockholders
-141,429.00
-141,429.00
-112,325.00
-70,511.00
-59,780.00
Diluted NI Available to Com Stockholders
-141,429.00
-141,429.00
-112,325.00
-70,511.00
-59,780.00
Basic EPS
-2.65
-2.92
-2.40
-1.64
-2.02
Diluted EPS
-2.65
-2.92
-2.40
-1.64
-2.02
Basic Average Shares
47,215.75
48,449.00
46,888.00
42,870.00
29,640.00
Diluted Average Shares
47,215.75
48,449.00
46,888.00
42,870.00
29,640.00
Total Operating Income as Reported
-154,542.00
-154,542.00
-115,234.00
-71,243.00
-63,354.00
Total Expenses
148,925.00
148,925.00
109,453.00
73,799.00
56,990.00
Net Income from Continuing & Discontinued Operation
-141,429.00
-141,429.00
-112,325.00
-70,511.00
-59,780.00
Normalized Income
-142,042.00
-142,042.00
-107,096.00
-68,926.10
-48,622.81
EBIT
-142,042.00
-142,042.00
-107,096.00
-69,148.00
-49,572.00
EBITDA
-139,034.00
-139,034.00
-104,200.00
-66,080.00
-45,643.00
Reconciled Depreciation
3,008.00
3,008.00
2,896.00
3,068.00
3,929.00
Net Income from Continuing Operation Net Minority Interest
-141,429.00
-141,429.00
-112,325.00
-70,511.00
-59,780.00
Total Unusual Items Excluding Goodwill
613.00
613.00
-5,229.00
-1,590.00
-11,375.00
Total Unusual Items
613.00
613.00
-5,229.00
-1,590.00
-11,375.00
Normalized EBITDA
-139,647.00
-139,647.00
-98,971.00
-64,490.00
-34,268.00
Tax Rate for Calcs
--
--
--
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-5.10
-217.81
12/31/2020 - 5/15/1986
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

CGEM Cullinan Therapeutics, Inc.
18.06
+1.01%
 
EWTX Edgewise Therapeutics, Inc.
15.45
-1.28%
 
NUVL Nuvalent, Inc.
63.06
-1.85%
 
DNTH Dianthus Therapeutics, Inc.
23.63
+1.24%
 
JSPR Jasper Therapeutics, Inc.
23.21
-2.56%
 
ELVN Enliven Therapeutics, Inc.
17.67
+2.14%
 
MRUS Merus N.V.
40.47
-1.41%
 
BPMC Blueprint Medicines Corporation
88.90
+0.59%
 
ARVN Arvinas, Inc.
34.29
+2.51%
 
NGNE Neurogene Inc.
31.58
-6.12%